Literature DB >> 19159939

[Clinical and serological findings of giant-cell arteritis].

P Vaith1, K Warnatz.   

Abstract

Giant cell arteritis (GCA) frequently appears as cranial arteritis (eg. temporal arteritis) with headache, pain on chewing and visual disturbances. In addition, extracranial manifestations are often observed leading to aneurysmatic dilatations and dissections of the aorta as well as stenoses of large thoracic, abdominal or limb arteries. The vascular signs are accompanied by general disease symptoms, e.g. malaise, elevated temperatures, weight loss and depression. Polymyalgia rheumatica (PMR) is the most frequent rheumatic manifestation of GCA but also occurs independently from GCA. The structural correlate for the PMR symptoms is first and foremost extra-articular inflammation (tenosynovitis, bursitis) of large joints and the vertebral column (interspinal bursitis). In addition, vasculitis of large arteries in PMR must be considered particularly in the presence of high inflammatory activity. While specific laboratory markers for GCA and PMR are lacking elevated values for the erythrocyte sedimentation rate and C-reactive protein are present in almost all patients at disease onset. Besides the clinical evaluation, the serological acute phase reaction represents the main parameter for the course during therapy of this relatively frequent disease in elderly people.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19159939     DOI: 10.1007/s00393-008-0377-3

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  47 in total

Review 1.  Does this patient have temporal arteritis?

Authors:  Gerald W Smetana; Robert H Shmerling
Journal:  JAMA       Date:  2002-01-02       Impact factor: 56.272

2.  Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan.

Authors:  Christian Agard; Jacques-H Barrier; Benoît Dupas; Thierry Ponge; Alfred Mahr; Gérard Fradet; Pascal Chevalet; Agathe Masseau; Eric Batard; Pierre Pottier; Bernard Planchon; Jean-Marie Brisseau; Mohamed-A Hamidou
Journal:  Arthritis Rheum       Date:  2008-05-15

3.  Circulating levels of IL-1beta, IL-6 and soluble IL-2 receptor in polymyalgia rheumatica and giant cell arteritis and rheumatoid arthritis.

Authors:  G Pountain; B Hazleman; T E Cawston
Journal:  Br J Rheumatol       Date:  1998-07

4.  Neurologic disease in biopsy-proven giant cell (temporal) arteritis.

Authors:  R J Caselli; G G Hunder; J P Whisnant
Journal:  Neurology       Date:  1988-03       Impact factor: 9.910

5.  A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis.

Authors:  G Myklebust; J T Gran
Journal:  Br J Rheumatol       Date:  1996-11

6.  Complement activation by C-reactive protein on the HEp-2 cell substrate.

Authors:  P Vaith; V Prasauskas; L A Potempa; H H Peter
Journal:  Int Arch Allergy Immunol       Date:  1996-10       Impact factor: 2.749

7.  Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis.

Authors:  N E Roche; J W Fulbright; A D Wagner; G G Hunder; J J Goronzy; C M Weyand
Journal:  Arthritis Rheum       Date:  1993-09

8.  Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.

Authors:  T Y Chuang; G G Hunder; D M Ilstrup; L T Kurland
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391

9.  Role of thrombocytosis in diagnosis of giant cell arteritis and differentiation of arteritic from non-arteritic anterior ischemic optic neuropathy.

Authors:  F Costello; M B Zimmerman; P A Podhajsky; S S Hayreh
Journal:  Eur J Ophthalmol       Date:  2004 May-Jun       Impact factor: 2.597

10.  Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients.

Authors:  Daniël Blockmans; Liesbet de Ceuninck; Steven Vanderschueren; Daniël Knockaert; Luc Mortelmans; Herman Bobbaers
Journal:  Arthritis Rheum       Date:  2006-02-15
View more
  3 in total

Review 1.  The diagnosis and treatment of giant cell arteritis.

Authors:  Thomas Ness; Thorsten A Bley; Wolfgang A Schmidt; Peter Lamprecht
Journal:  Dtsch Arztebl Int       Date:  2013-05-24       Impact factor: 5.594

2.  Cerebral Phosphorus Magnetic Resonance Spectroscopy in a Patient with Giant Cell Arteritis and Endovascular Therapy.

Authors:  Ruth Steiger; Lisa-Maria Walchhofer; Andreas Rietzler; Katherina J Mair; Michael Knoflach; Bernhard Glodny; Elke R Gizewski; Astrid E Grams
Journal:  Case Rep Radiol       Date:  2018-10-28

Review 3.  Headache and immunological/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms.

Authors:  Leonardo Biscetti; Gioacchino De Vanna; Elena Cresta; Ilenia Corbelli; Lorenzo Gaetani; Letizia Cupini; Paolo Calabresi; Paola Sarchielli
Journal:  J Neuroinflammation       Date:  2021-11-08       Impact factor: 8.322

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.